NEOGEN CORP (NEOG)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for NEOG
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| NEOG | Director; Executive Vice President of Rapid and Molecular Diagnostics; Member | 57 | ["nearly 30 years of diagnostics and healthcare experience", "led three global businesses at Abbott Laboratories", "held leadership roles across pharmaceuticals, renal care, animal health, and molecular diagnostics"] | ["Audit", "Science, Technology and Innovation", "Science, Technology and Innovation Committee"] | 2025 |
Biography sourced from the proxy statement filing.
Andrea Wainer brings nearly 30 years of diagnostics and healthcare experience to Neogen's Board of Directors. Most recently, she was Executive Vice President of Rapid and Molecular Diagnostics at Abbott Laboratories, where she led three global businesses spanning molecular diagnostics, rapid point-of-care testing, and handheld diagnostic devices. Since joining Abbott in 1997, Ms. Wainer held leadership roles across pharmaceuticals, renal care, animal health, and molecular diagnostics. She also serves on the Board of Directors of Analog Devices, Inc. (Nasdaq: ADI) and the Board of Trustees of the Goodman Theatre in Chicago.